Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs

[1]  Ying-hong Li,et al.  Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR). , 2022, European journal of medicinal chemistry.

[2]  Y. Kanda,et al.  Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance. , 2022, Journal of pharmacological and toxicological methods.

[3]  Zhiyun Wang,et al.  Discovery of the radio-protecting effect of Ecliptae Herba, its constituents and targeting p53-mediated apoptosis in vitro and invivo , 2022, Acta pharmaceutica Sinica. B.

[4]  Early-onset fulminant neonatal sepsis caused by Multi-Drug Resistant and ESBL producing E. coli (CTX-M gene) in a late-preterm neonate: case report and literature review. , 2022, The New Microbiologica.

[5]  J. Sun,et al.  Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era , 2022, Acta pharmaceutica Sinica. B.

[6]  G. Stroffolini,et al.  Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians , 2022, Pharmaceuticals.

[7]  Youchun Wang,et al.  Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism , 2022, European Journal of Medicinal Chemistry.

[8]  C. Alabi,et al.  Mechanism of Action and Resistance Evasion of an Antimicrobial Oligomer against Multidrug-Resistant Gram-Negative Bacteria. , 2022, ACS applied bio materials.

[9]  K. Bowker,et al.  Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. , 2022, Journal of Antimicrobial Chemotherapy.

[10]  R. Laxminarayan.  The overlooked pandemic of antimicrobial resistance , 2022, The Lancet.

[11]  De-qing Wang,et al.  In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales , 2021, Frontiers in Cellular and Infection Microbiology.

[12]  D. Yahav,et al.  New evidence for managing Gram-negative bloodstream infections , 2021, Current opinion in infectious diseases.

[13]  D. Willbold,et al.  Interaction Mode of the Novel Monobactam AIC499 Targeting Penicillin Binding Protein 3 of Gram-Negative Bacteria , 2021, Biomolecules.

[14]  B. Kshiar,et al.  Trifluoroacetic Acid-Mediated Oxidative Self-Condensation of Acetophenones in the Presence of SeO2: A Serendipitous Approach for the Synthesis of Fused [1,3]Dioxolo[4,5-d][1,3]dioxoles , 2021, ACS omega.

[15]  Wei Wei,et al.  Berberine Directly Targets the NEK7 Protein to Block the NEK7-NLRP3 Interaction and Exert Anti-inflammatory Activity. , 2020, Journal of medicinal chemistry.

[16]  Yuxiu Liu,et al.  Electrochemical decarboxylative C3 alkylation of quinoxalin-2(1H)-ones with N-hydroxyphthalimide esters. , 2020, Chemical communications.

[17]  L. Salazar-Ospina,et al.  Post-antibiotic era in hemodialysis? Two case reports of simultaneous colonization and bacteremia by multidrug-resistant bacteria , 2020, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[18]  Zhuo-rong Li,et al.  Design, Synthesis, and Bioactivity of Cyclic Lipopeptide Antibiotics with Varied Polarity, Hydrophobicity, and Positive Charge Distribution. , 2020, ACS infectious diseases.

[19]  H. Fu,et al.  Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue. , 2019, Bioorganic chemistry.

[20]  Qiang Liu,et al.  Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage. , 2018, European journal of medicinal chemistry.

[21]  T. Talele.  Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry. , 2017, Journal of medicinal chemistry.

[22]  S. Krähenbühl,et al.  Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072 , 2017, Archives of Toxicology.

[23]  Jian-Dong Jiang,et al.  Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria. , 2016, European journal of medicinal chemistry.

[24]  Jing-pu Zhang,et al.  Cardiotoxicity evaluation of anthracyclines in zebrafish (Danio rerio) , 2015, Journal of applied toxicology : JAT.

[25]  D. F. Basri,et al.  Pharmacodynamic Interaction of Quercus infectoria Galls Extract in Combination with Vancomycin against MRSA Using Microdilution Checkerboard and Time-Kill Assay , 2012, Evidence-based complementary and alternative medicine : eCAM.

[26]  M. Page,et al.  In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli , 2010, Antimicrobial Agents and Chemotherapy.

[27]  S. Sieber,et al.  Beta-lactams as selective chemical probes for the in vivo labeling of bacterial enzymes involved in cell wall biosynthesis, antibiotic resistance, and virulence. , 2008, Journal of the American Chemical Society.

[28]  J. M. Shaw,et al.  Disposition of [14C]aztreonam in rats, dogs, and monkeys , 1984, Antimicrobial Agents and Chemotherapy.

[29]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[30]  OUP accepted manuscript , 2022, Journal of Antimicrobial Chemotherapy.

[31]  Z. Muhi-eldeen,et al.  Synthesis and pharmacological evaluation of N-(4-(t-amino)-2- butynyloxy) phthalimides , 2012 .

[32]  J. Karlowsky,et al.  Ceftobiprole , 2008, American journal of clinical dermatology.

[33]  J. Ghuysen,et al.  Serine beta-lactamases and penicillin-binding proteins. , 1991, Annual review of microbiology.

[34]  J. M. Shaw,et al.  Disposition of [ 14 C ] Aztreonam in Rats , Dogs , and Monkeys , 2022 .